Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →

Clinical Trials Directory

Browse and search research studies sourced from ClinicalTrials.gov and our partner researchers.

47,402 studies found

Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and E...

Conditions: Treatment Resistant Depression

University of Alabama at Birmingham Birmingham Alabama

View details
Active Not Recruiting
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in...

Conditions: Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Mel...

Conditions: Melanoma of Unknown Primary, Recurrent Melanoma, Stage IIIB Cutaneous Melanoma A...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed...

Conditions: Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
Serial Assessment of Body Fat Accrual in Very Preterm Infants

Conditions: Infant,Premature, Body Weight, Adiposity

University of Alabama at Birmingham Birmingham Alabama

View details
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving...

Conditions: Type 2 Diabetes

Central Research Associates, LLC dba Flourish Research...

View details
Active Not Recruiting
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capi...

Conditions: Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial S...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Be...

Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Can...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Niv...

Conditions: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamo...

Veterans Administration Medical Center - Birmingham Bir...

View details
Active Not Recruiting
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjec...

Conditions: Partial Lipodystrophy

University of Alabama Birmingham Alabama

View details
Recruiting
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalae...

Conditions: Hyperkalaemia

Research Site Birmingham Alabama

View details
Active Not Recruiting
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell C...

Conditions: Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV R...

Children's Hospital of Alabama Birmingham Alabama

View details
Active Not Recruiting
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk H...

Conditions: Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Foll...

Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melan...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Recruiting
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC

Conditions: Non Small Cell Lung Cancer

University of Alabama at Birmingham Birmingham Alabama

View details
Recruiting
Radiation Free Study

Conditions: Aortic Aneurysm

University of Alabama Birmingham Alabama

View details
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versu...

Conditions: Acute Myeloid Leukemia

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both...

Conditions: Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clini...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Active Not Recruiting
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (...

Conditions: Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advan...

University of Alabama at Birmingham Cancer Center Birmi...

View details
Recruiting
Histiocytic Disorder Follow-up Study

Conditions: Histiocytosis, Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai Dor...

University of Alabama at Birmingham Birmingham Alabama

View details
Active Not Recruiting
Neuroblastoma Maintenance Therapy Trial

Conditions: Neuroblastoma

University of Alabama, Children's of Alabama Birmingham...

View details
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Tr...

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

University of Alabama at Birmingham ( Site 0006) Birmin...

View details
Active Not Recruiting
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Tel...

Conditions: Hereditary Hemorrhagic Telangiectasia

Clinical Trial Site Birmingham Alabama

View details
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory De...

University of Alabama at Birmingham - 1720 University B...

View details